| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Roivant Sciences Ltd. | Pres&Chief Investment Officer, Director | Common Shares | 22.5M | $243M | $10.80 | Jul 26, 2024 | Direct |
| Roivant Sciences Ltd. | Pres&Chief Investment Officer, Director | Common Shares | 1.66M | $17.9M | $10.80 | Jul 26, 2024 | By LLC |
| Roivant Sciences Ltd. | Pres&Chief Investment Officer, Director | Capped Value Appreciation Rights | 0 | $0 | $6.40 | Mar 30, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | Jul 26, 2024 | 2 | $0 | 4 | Jul 30, 2024 | Pres&Chief Investment Officer, Director |
| ROIV | Roivant Sciences Ltd. | Mar 30, 2024 | 3 | -$15.7M | 4 | Apr 2, 2024 | Pres&Chief Investment Officer, Director |
| ROIV | Roivant Sciences Ltd. | Dec 27, 2023 | 3 | -$1.34M | 4 | Dec 29, 2023 | Pres&Chief Investment Officer |
| ROIV | Roivant Sciences Ltd. | Sep 27, 2023 | 3 | -$666K | 4 | Sep 29, 2023 | Pres&Chief Investment Officer |
| ROIV | Roivant Sciences Ltd. | Aug 27, 2023 | 2 | -$339K | 4 | Aug 29, 2023 | Pres&Chief Investment Officer |
| ROIV | Roivant Sciences Ltd. | Jul 27, 2023 | 2 | -$679K | 4 | Jul 31, 2023 | Pres&Chief Investment Officer |
| ROIV | Roivant Sciences Ltd. | May 27, 2023 | 2 | -$2.04M | 4 | May 31, 2023 | Pres & Chief Investment Officer |
| ROIV | Roivant Sciences Ltd. | Apr 20, 2022 | 1 | $0 | 4 | Apr 22, 2022 | Pres & Chief Investment Officer |
| ROIV | Roivant Sciences Ltd. | Oct 1, 2021 | 0 | $0 | 3 | Oct 1, 2021 | Pres &Chief Investment Officer |